prof. Maciej Kupczyk (Łódź, Poland)

1. Theoretical introduction
   dr Emilia Majsiak (Lublin, Poland)
   8:00 AM - 8:20 AM
2. Practical introduction (2-3 clinical cases)
   dr Łukasz Błażowski (Rabka-Zdrój, Poland)
   8:20 AM - 8:40 AM
3. Q&A Session
   
   8:40 AM - 9:00 AM

organised within the framework of the research and training grant awarded by EMMA

dr Anna Groblewska (Łódź, Poland)

1. Allergic conjunctivitis – safety and efficacy of specific immunotherapy
   prof. Marta Chełmińska (Gdańsk, Poland)
   9:00 AM - 9:25 AM
2. Is entopy relevant in eye allergy?
   dr Ewa Bogacka (Wrocław, Poland)
   9:25 AM - 9:50 AM
3. Distinct features of allergic conjunctivitis in children and adolescents
   dr Anna Groblewska (Łódź, Poland)
   9:50 AM - 10:15 AM
4. Discussion
   
   10:15 AM - 10:30 AM

organised within the framework of the research and training grant awarded by PTA

prof. Krzysztof Kowal (Białystok, Poland)

1. Latest standards for allergen immunotherapy
   prof. Barbara Rogala (Katowice, Poland)
   9:00 AM - 9:20 AM
2. Insect venom allergy in children
   dr hab. Ewa Cichocka-Jarosz (Kraków, Poland)
   9:20 AM - 9:40 AM
3. Allergen immunotherapy in local allergic diseases
   prof. Andrzej Bożek (Katowice, Poland)
   9:40 AM - 10:00 AM
4. Can laboratory tests help predict the effectiveness of AIT?
   prof. Krzysztof Kowal (Białystok, Poland)
   10:00 AM - 10:20 AM
5. Discussion
   
   10:20 AM - 10:30 AM

organised within the framework of the research and training grant awarded by PTA

prof. Maciej Kupczyk (Łódź, Poland), prof. Marek Kulus (Warszawa, Poland)

1. Trained immunity and tolerance during allergen-specific immunotherapy
   
   10:30 AM - 10:45 AM

   A. Eljaszewicz, F. Ruchtia, U. Radzikowska, A. Globinska, T. Boonpiyathad, A. Gschwend, H. Morita, A. Helbling, S. Arasia, H. Kahlert, N. Berek, A. Nandy, M. Akdis, C. Willers, M. Moniuszko, C. A. Akdis, M. Sokolowska
   
   Uniwersytet Medyczny w Białymstoku

2. Interferon-dependant mechanisms of antiviral resistance of the human lung vascular endothelium infected with rhinovirus HRV16 – relevance in asthma exacerbations
   
   10:45 AM - 11:00 AM

   M. Gawrysiak¹, M. Szymański¹, M. Kobierecki¹, A. Gajewski¹, R. Szewczyk¹, I. Gulbas¹, A. Likońska¹, S. Michlewska², M. L Kowalski¹, M. Chałubiński<sup>1
   
   1</sup> Department of Immunology and Allergy, Medical University of Lodz, Lodz, Poland
   ² Laboratory of Microscopic Imaging and Specialized Biological Techniques, University of Lodz, Lodz, Poland

3. OM-85 BV w terapii pyłkowego nieżytu nosa u dzieci – doniesienie wstępne
   
   11:00 AM - 11:15 AM

   A. Jędrzejewski^1,2., E. Wawryk-Gawda¹, A. Bodajko-Grochowska¹, A. Emeryk^1,2.
   
   ¹ Katedra i Zakład Pielęgniarstwa Pediatrycznego, Uniwersytet Medyczny w Lublinie
   ² Klinika Chorób Płuc i Reumatologii, Uniwersytet Medyczny w Lublinie

4. Health literacy as a barrier to vaccine accessibility in people suffering from allergic diseases
   
   11:15 AM - 11:30 AM

   P. Łacwik, M. Kupczyk, C. Pałczyński
   
   Collegium Medicum, Uniwersytet Jana Kochanowskiego w Kielcach; Klinika Chorób Wewnętrznych, Astmy i Alergii, Uniwersytet Medyczny w Łodzi

5. Wpływ mikrobiomu mleka matki na kształtowanie się mikrobiom kału i skóry u dzieci z chorobami alergicznymi
   
   11:30 AM - 11:45 AM

   E. Łoś-Rycharska, M. Gołębiewski, M. Sikora, J. Gawryjołek, T. Grzybowski, M. Gorzkiewicz, A. Krogulska
   
   Katedra i Klinika Pediatrii, Alergologii i Gastroenterologii, Collegium Medicum w Bydgoszczy Uniwersytetu Mikołaja Kopernika w Toruniu

6. Understanding of mesenchymal stem cells (MSCs) immunoregulatory mechanism in the eosinophilic and neutrophilic lung inflammation
   
   11:45 AM - 12:00 PM

   M. Tynecka¹, A. Janucik¹, M. Niemira², A. Starosz¹, A. Zbikowski³, K. Grubczak¹, D. Groth¹, A. Szalkowska², U. Korotko⁴, M. Lukasik⁵, J. Reszec⁵, M. Kwasniewski⁴, A. Kretowski^2,6, M. Moniuszko^1,7, A. Eljaszewicz<sup>1
   
   1</sup> Department of Regenerative Medicine and Immune Regulation
   ² Clinical Research Centre
   ³ Department of Medical Biology
   ⁴ Centre for Bioinformatics and Data Analysis
   ⁵ Department of Medical Pathomorphology
   ⁶ Department of Endocrinology, Diabetology and Internal Medicine
   ⁷ Clinical Department of Allergic and Internal Diseases; Medical University of Bialystok, Bialystok, Poland

organised within the framework of the research and training grant awarded by PTA

Selection of the best of 6 papers submitted to the Congress of the Polish Society of Allergology (each presentation 10 minutes long)

prof. Radosław Gawlik (Katowice, Poland), prof. Marcin Kurowski (Łódź, Poland)

1. Physioprophylaxis in children and adolescents with asthma
   dr hab. Anna Brzęk (Katowice, Poland)
   10:30 AM - 10:55 AM
2. Ultra endurance sports: are they just becoming more popular, or do they also involve a greater risk of allergy and anaphylaxis?
   prof. Marcin Kurowski (Łódź, Poland)
   10:55 AM - 11:20 AM
3. Urticaria and sport: current knowledge and challenges in allergy practice
   prof. Elena Borzova (Moscow, Russia)
   11:20 AM - 11:45 AM
4. Discussion
   
   11:45 AM - 12:00 PM

organised within the framework of the research and training grant awarded by PTA

prof. Zbigniew Bartuzi (Bydgoszcz, Poland)

1. From molecule to epitopes. Epitope diagnostics the future of modern allergology
   prof. Zbigniew Bartuzi (Bydgoszcz, Poland)
   12:30 PM - 12:50 PM
2. Anaphylaxis after food intake in infants
   prof. Aneta Krogulska (Bydgoszcz, Poland)
   12:50 PM - 1:10 PM
3. Rare forms of polyvalent food allergy in children
   prof. Maciej Kaczmarski (Białystok, Poland)
   1:10 PM - 1:30 PM
4. Eosinophilic esophagitis – a current interdisciplinary clinical problem
   dr Oksana Wojas (Warszawa, Poland)
   1:30 PM - 1:50 PM
5. Discussion
   
   1:50 PM - 2:00 PM

organised within the framework of the research and training grant awarded by PTA

prof. Grażyna Bochenek (Kraków, Poland)

1. Hypersensitivity to different groups of biological drugs
   prof. Marita Nittner-Marszalska (Wrocław, Poland)
   2:00 PM - 2:20 PM
2. The role of the MRGPRX2 receptor in drug-induced hypersensitivity reactions
   dr hab. Grzegorz Porębski (Kraków, Poland)
   2:20 PM - 2:40 PM
3. Hypersensitivity to new oral anticoagulants (NOAC)
   dr Aleksandra Wardzyńska (Łódź, Poland)
   2:40 PM - 3:00 PM
4. Hypersensitivity to chemotherapeutic agents
   dr hab. Joanna Glück (Katowice, Poland)
   3:00 PM - 3:20 PM
5. Summary and discussion
   
   3:20 PM - 3:30 PM

organised within the framework of the research and training grant awarded by PTA